Sushilan Vasoo
Président chez Seacare Education Pte Ltd.
Profil
Sushilan Vasoo is currently the Chairman of Seacare Education Pte Ltd, Director of Singapore Press Holdings Foundation Ltd, and Director of TauRx Pharmaceuticals Ltd.
Previously, he served as an Independent Director at Ascent Bridge Ltd from 2003 to 2021 and as a Director at TauRx Therapeutics Ltd.
Postes actifs de Sushilan Vasoo
Sociétés | Poste | Début |
---|---|---|
Seacare Education Pte Ltd. | Président | 10/05/2010 |
TauRx Pharmaceuticals Ltd.
TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | Directeur/Membre du Conseil | - |
Singapore Press Holdings Foundation Ltd. | Directeur/Membre du Conseil | - |
Anciens postes connus de Sushilan Vasoo
Sociétés | Poste | Fin |
---|---|---|
ASCENT BRIDGE LIMITED | Directeur/Membre du Conseil | 28/04/2021 |
TauRx Therapeutics Ltd.
TauRx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology TauRx Therapeutics Ltd. develops treatments and diagnostics for a range of neurodegenerative diseases. It offers tau aggregation inhibitor, LMTX, a global Phase 3 clinical trials for Alzheimer’s and behavioural-variant Frontotemporal Dementia (bvFTD). LMTXT. The company was founded by Claude Wischik and K M Seng in 2002 and is headquartered in Singapore. | Directeur/Membre du Conseil | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
ASCENT BRIDGE LIMITED | Producer Manufacturing |
Entreprise privées | 4 |
---|---|
Singapore Press Holdings Foundation Ltd. | |
TauRx Therapeutics Ltd.
TauRx Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology TauRx Therapeutics Ltd. develops treatments and diagnostics for a range of neurodegenerative diseases. It offers tau aggregation inhibitor, LMTX, a global Phase 3 clinical trials for Alzheimer’s and behavioural-variant Frontotemporal Dementia (bvFTD). LMTXT. The company was founded by Claude Wischik and K M Seng in 2002 and is headquartered in Singapore. | Health Technology |
Seacare Education Pte Ltd. | |
TauRx Pharmaceuticals Ltd.
TauRx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology TauRx Pharmaceuticals Ltd. developes drugs and diagnostics for neurodegenerative diseases. its pipeline includes LMTX, a tau aggregation inhibitor (TAI) for Alzheimer?s and Behavioural variant frontotemporal dementia diseases; anti-synuclein, a synuclein protein; early-stage compounds for use in therapies for neurodegenerative diseases; and diagnostic tests that assist clinicians in detecting and confirming the nature of a disease and monitoring the effects of therapy. The company was founded by Claude Wischik in 2002 and is headquartered in Singapore. | Health Technology |